What diseases can benefit from GcMAF therapy?

What diseases can benefit from GcMAF therapy?

Gc-MAF and/or oral Colostrum MAF macrophage activation therapy is indicated in the treatment of any diseases where there is immune disfunction or where the immune system is compromised, such as:

Cancer Autoimmune diseases Respiratory tract infections
Autism Spectrum Disorders (ASD) Herpes Simplex virus (HSV) Epstein-Barr Virus (EBV)
Chronic Fatigue Syndrome (CFS) Multiple sclerosis (MS) Cystitis
Myalgic Encephalomyelitis (ME) Rheumatoid arthritis (RA) Urinary tract infection (UTI)
Tuberculosis Lyme disease (Lyme borreliosis) Endometriosis
Lupus (Systemic lupus erythematosus, SLE) Mycobacteria infections Parkinson’s disease
Pneumonia infection Fibromyalgia Norovirus
Malaria Warts caused by viral infection Herpes simplex virus (HSV)
Q fever (Coxiella burnetii) Influenza virus (flu) Chicken pox (varicella zoster virus)
Psoriasis Polycystic ovary syndrome (PCOS) Ulcerative colitis, Crohn’s disease

Older post Newer post